Citadel Advisors »

Unity Biotechnology shares owned by Citadel Advisors

Quarter-by-quarter ownership of Unity Biotechnology (UBX) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Unity Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Unity Biotechnology held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Unity Biotechnology by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $131k 68k 1.93
2023-09-30 $129k 54k 2.40
2023-06-30 $153k 60k 2.55
2023-03-31 $60k 37k 1.63
2022-12-31 $129k 47k 2.74

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Booking Holdings Call Option (BKNG)

View all positions for Citadel Advisors

Top funds holding Unity Biotechnology

Alyeska Investment Group
Arch Venture Corp
Vanguard Group
Citadel Advisors
Founders Fund V Management
Wells Fargo & Company
Cercano Management
Jane Street
Dimensional Fund Advisors
Commonwealth Equity Services
Laurion Capital Management
Millennium Management
Advisor Group Holdings
Wolverine Trading
UBS Group

View all funds holding Unity Biotechnology